M. Zakarija

1.9k total citations
47 papers, 1.5k citations indexed

About

M. Zakarija is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, M. Zakarija has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Molecular Biology and 14 papers in Physiology. Recurrent topics in M. Zakarija's work include Thyroid Disorders and Treatments (30 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Ion channel regulation and function (7 papers). M. Zakarija is often cited by papers focused on Thyroid Disorders and Treatments (30 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Ion channel regulation and function (7 papers). M. Zakarija collaborates with scholars based in Canada, United States and Croatia. M. Zakarija's co-authors include J. M. McKenzie, Atsuko Sato, Francis J. Hornicek, Donald Munro, Margaret Eidson, C. H. BASTOMSKY, Joan Stein‐Streilein, Natalia García-García, K J Olsen and Silvina Levis and has published in prestigious journals such as Journal of Clinical Investigation, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

M. Zakarija

46 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Zakarija Canada 22 1.1k 408 287 234 217 47 1.5k
WILLIAM A. VALENTE United States 16 833 0.8× 343 0.8× 214 0.7× 183 0.8× 139 0.6× 23 1.3k
Barbara Czarnocka Poland 22 989 0.9× 415 1.0× 292 1.0× 188 0.8× 292 1.3× 71 1.5k
M Weissel Austria 19 454 0.4× 230 0.6× 135 0.5× 82 0.4× 151 0.7× 101 1.2k
Werner Joba Germany 19 770 0.7× 298 0.7× 182 0.6× 91 0.4× 80 0.4× 24 1.3k
Hironori Kimura Japan 22 492 0.5× 317 0.8× 173 0.6× 85 0.4× 305 1.4× 52 1.1k
Michael Derwahl Germany 27 1.3k 1.2× 704 1.7× 441 1.5× 90 0.4× 84 0.4× 57 2.0k
Jody Ginsberg Canada 18 684 0.6× 275 0.7× 153 0.5× 113 0.5× 44 0.2× 54 1.1k
V. Pezzino Italy 28 1.5k 1.4× 1.4k 3.4× 218 0.8× 198 0.8× 59 0.3× 70 2.6k
Josiah Brown United States 19 606 0.6× 259 0.6× 250 0.9× 136 0.6× 51 0.2× 36 1.2k
Takahiko Kogai Japan 24 1.3k 1.2× 860 2.1× 312 1.1× 53 0.2× 75 0.3× 47 2.0k

Countries citing papers authored by M. Zakarija

Since Specialization
Citations

This map shows the geographic impact of M. Zakarija's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Zakarija with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Zakarija more than expected).

Fields of papers citing papers by M. Zakarija

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Zakarija. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Zakarija. The network helps show where M. Zakarija may publish in the future.

Co-authorship network of co-authors of M. Zakarija

This figure shows the co-authorship network connecting the top 25 collaborators of M. Zakarija. A scholar is included among the top collaborators of M. Zakarija based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Zakarija. M. Zakarija is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zakarija, M. & J. M. McKenzie. (2009). Autoantibodies to the TSH Receptor. Experimental and Clinical Endocrinology & Diabetes. 97(02/03). 165–169.
2.
Zakarija, M., J. M. McKenzie, & Margaret Eidson. (1990). Transient Neonatal Hypothyroidism: Characterization of Maternal Antibodies to the Thyrotropin Receptor*. The Journal of Clinical Endocrinology & Metabolism. 70(5). 1239–1246. 63 indexed citations
3.
Alves, Crésio, Margaret Eidson, M. Zakarija, & J. M. McKenzie. (1989). Graves disease presenting as painful thyroiditis. European Journal of Pediatrics. 148(7). 603–604. 5 indexed citations
4.
Zakarija, M. & J. M. McKenzie. (1989). Variations in the Culture Medium for FRTL5 Cells: Effects on Growth and Iodide Uptake*. Endocrinology. 125(3). 1253–1259. 29 indexed citations
5.
Banovac, Krešimir, M. Zakarija, & Alexander Rabinovitch. (1989). A Study of Hepatic Metabolism of Thyroxine in BB/W Rats Treated with L-Thyroxine. Hormone and Metabolic Research. 21(2). 69–72. 1 indexed citations
6.
Zakarija, M. & J. M. McKenzie. (1989). Influence of Cytokines on Growth and Differentiated Function of FRTL5 Cells*. Endocrinology. 125(3). 1260–1265. 29 indexed citations
7.
McKenzie, J. M. & M. Zakarija. (1989). Clinical Review 3 The Clinical Use of Thyrotropin Receptor Antibody Measurements*. The Journal of Clinical Endocrinology & Metabolism. 69(6). 1093–1096. 76 indexed citations
8.
Zakarija, M., Sungho Jin, & J. M. McKenzie. (1988). Evidence supporting the identity in Graves' disease of thyroid-stimulating antibody and thyroid growth-promoting immunoglobulin G as assayed in FRTL5 cells.. Journal of Clinical Investigation. 81(3). 879–884. 30 indexed citations
9.
Banovac, Krešimir, Latifa Ghandur‐Mnaymneh, M. Zakarija, Alexander Rabinovitch, & J. M. McKenzie. (1988). The Effect of Thyroxine on Spontaneous Thyroiditis in BB/W Rats. International Archives of Allergy and Immunology. 87(3). 301–305. 7 indexed citations
10.
Zakarija, M., Francis J. Hornicek, Silvina Levis, & J. M. McKenzie. (1988). Effects of γ-interferon and tumor necrosis factor α on thyroid cells: induction of class II antigen and inhibition of growth stimulation. Molecular and Cellular Endocrinology. 58(2-3). 129–136. 41 indexed citations
11.
Stein‐Streilein, Joan, et al.. (1987). Suppression of peripheral blood natural killer cell activity by excess thyroid hormone.. Journal of Clinical Investigation. 79(2). 404–408. 52 indexed citations
12.
Hornicek, Francis J., et al.. (1986). Evidence that Adenosine 3′,5′-Monophosphate Mediates Stimulation of Thyroid Growth in FRTL5Cells*. Endocrinology. 119(2). 802–810. 84 indexed citations
13.
Zakarija, M.. (1983). Immunochemical characterization of the thyroid-stimulating antibody (TSAb) of Graves' disease: evidence for restricted heterogeneity.. PubMed. 10(2). 77–85. 34 indexed citations
14.
Loveridge, N., M. Zakarija, Lucille Bitensky, & J. M. McKenzie. (1979). The Cytochemical Bioassay for Thyroid-Stimulating Antibody of Graves' Disease: Further Experience*. The Journal of Clinical Endocrinology & Metabolism. 49(4). 610–615. 20 indexed citations
15.
McKenzie, J. M. & M. Zakarija. (1978). Pathogenesis of neonatal Graves’ disease. Journal of Endocrinological Investigation. 1(2). 183–189. 21 indexed citations
16.
McKenzie, J. M., M. Zakarija, & Atsuko Sato. (1978). Humoral immunity in Graves' disease. Clinics in Endocrinology and Metabolism. 7(1). 31–45. 77 indexed citations
17.
McKenzie, J. M. & M. Zakarija. (1977). LATS in Graves' Disease. Elsevier eBooks. 33. 29–57. 53 indexed citations
18.
McKenzie, J. M. & M. Zakarija. (1976). A Reconsideration of a Thyroid-Stimulating Immunoglobulin as the Cause of Hyperthyroidism in Graves' Disease. The Journal of Clinical Endocrinology & Metabolism. 42(4). 778–781. 93 indexed citations
19.
McKenzie, J. M., M. Zakarija, & M. Bonnyns. (1975). Graves' Disease. Medical Clinics of North America. 59(5). 1177–1192. 8 indexed citations
20.
Zakarija, M. & J. M. McKenzie. (1973). Effect of thyrotropin and of LATS on mouse thyroid cyclic AMP. Metabolism. 22(9). 1185–1191. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026